Search all trials

Find therapies in clinical trials near you – page 26

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Colitis ulcerative

Not recruiting

Investigational

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Rifamycin Sodium

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Crizotinib

Contact Research Centre

Gastric cancer

Not recruiting

Registered drug

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Gastric cancer

Not recruiting

Registered drug

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Xevinapant

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Human Serum Albumin

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Investigational

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Non-small cell lung cancer stage IV

Not recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drug

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Find therapies in clinical trials near you – page 26

427 trials match your criteria

Colitis ulcerative

Study on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis

Non-small cell lung cancer

Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Gastric cancer

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Gastric cancer

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Squamous cell carcinoma of head and neck

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Hepatocellular carcinoma

Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

Hepatic cirrhosis

Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Hepatocellular carcinoma

Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

Psoriatic arthropathy

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Non-small cell lung cancer stage IV

Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Myelofibrosis+1

Study on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions

Malignant melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.